ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
9.13
-0.60 (-6.17%)
At close: Jun 5, 2026, 4:00 PM EDT
9.48
+0.35 (3.83%)
After-hours: Jun 5, 2026, 5:06 PM EDT
ProMIS Neurosciences Market Cap
ProMIS Neurosciences has a market cap or net worth of $81.88 million as of June 5, 2026. Its market cap has increased by 404.67% in one year.
Market Cap
81.88M
Enterprise Value
18.03M
1-Year Change
404.67%
Ranking
Category
Stock Price
$9.13
Market Cap Chart
Since April 16, 2012, ProMIS Neurosciences's market cap has increased from $21.82M to $81.88M, an increase of 275.20%. That is a compound annual growth rate of 9.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 81.88M | 457.34% |
| Dec 31, 2025 | 14.69M | -52.59% |
| Dec 31, 2024 | 30.98M | 42.66% |
| Dec 29, 2023 | 21.72M | -41.67% |
| Dec 30, 2022 | 37.23M | -24.28% |
| Dec 31, 2021 | 49.17M | 104.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pelthos Therapeutics | 89.88M |
| Rani Therapeutics Holdings | 89.69M |
| ImmuCell | 89.29M |
| OKYO Pharma | 88.17M |
| Anixa Biosciences | 87.84M |
| Atara Biotherapeutics | 87.42M |
| Aardvark Therapeutics | 86.61M |
| Rallybio | 85.69M |